Skip to content

Enveda raised $311 million in a series e round led by Catalio Capital Management, announced Sept. 22.

Facts

Company
Enveda
Amount
$311 million
Currency
USD
Stage
Series E
Announced
Sep 22, 2026
Instrument
Equity
Valuation
$2 billion (officially disclosed)

Investors

Participants
Iconiq

Use of funds

bring more nature-derived AI drugs into clinical trials

As stated by the company.

Sources

  1. 1.Enveda secures $311M to bring more nature-derived AI drugs into clinical trials — TechCrunch Startups, Sep 23, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026